AI brings savings to clinical trials: study

Artificial intelligence isn't just speeding up early-stage drug development, it's starting to unlock millions of dollars' worth of new efficiencies in clinical trials on cancer treatments, research shared first with Axios shows.Why it matters: AI-powered tools could shave months off time-consuming processes like recruiting and enrolling patien